Novartis Poised for Phase 3b SMART Study of Zolgensma & SMA Adventures

SMA News Today’s multimedia associate, Price Wooldridge, discusses how Novartis is poised for their Phase 3b SMART study of Zolgensma.

Also, DeAnn Runge shares a recent adventure she went on to a greenhouse in the country. She even talks about how she was caught off guard and how she handled the situation.

Are you interested in learning more about spinal muscular atrophy? If so, please visit https://smanewstoday.com/